Literature DB >> 22224556

CRISPR: new horizons in phage resistance and strain identification.

Rodolphe Barrangou1, Philippe Horvath.   

Abstract

Bacteria have been widely used as starter cultures in the food industry, notably for the fermentation of milk into dairy products such as cheese and yogurt. Lactic acid bacteria used in food manufacturing, such as lactobacilli, lactococci, streptococci, Leuconostoc, pediococci, and bifidobacteria, are selectively formulated based on functional characteristics that provide idiosyncratic flavor and texture attributes, as well as their ability to withstand processing and manufacturing conditions. Unfortunately, given frequent viral exposure in industrial environments, starter culture selection and development rely on defense systems that provide resistance against bacteriophage predation, including restriction-modification, abortive infection, and recently discovered CRISPRs (clustered regularly interspaced short palindromic repeats). CRISPRs, together with CRISPR-associated genes (cas), form the CRISPR/Cas immune system, which provides adaptive immunity against phages and invasive genetic elements. The immunization process is based on the incorporation of short DNA sequences from virulent phages into the CRISPR locus. Subsequently, CRISPR transcripts are processed into small interfering RNAs that guide a multifunctional protein complex to recognize and cleave matching foreign DNA. Hypervariable CRISPR loci provide insights into the phage and host population dynamics, and new avenues for enhanced phage resistance and genetic typing and tagging of industrial strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22224556     DOI: 10.1146/annurev-food-022811-101134

Source DB:  PubMed          Journal:  Annu Rev Food Sci Technol        ISSN: 1941-1421


  65 in total

1.  Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of shiga toxin-producing Escherichia coli.

Authors:  Magaly Toro; Guojie Cao; Wenting Ju; Marc Allard; Rodolphe Barrangou; Shaohua Zhao; Eric Brown; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2013-12-13       Impact factor: 4.792

Review 2.  Structure Principles of CRISPR-Cas Surveillance and Effector Complexes.

Authors:  Tsz Kin Martin Tsui; Hong Li
Journal:  Annu Rev Biophys       Date:  2015-05-27       Impact factor: 12.981

Review 3.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.

Authors:  Rodolphe Barrangou; Luciano A Marraffini
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

4.  CRISPR-based screening of genomic island excision events in bacteria.

Authors:  Kurt Selle; Todd R Klaenhammer; Rodolphe Barrangou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

5.  The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus.

Authors:  Jason Carte; Ross T Christopher; Justin T Smith; Sara Olson; Rodolphe Barrangou; Sylvain Moineau; Claiborne V C Glover; Brenton R Graveley; Rebecca M Terns; Michael P Terns
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

Review 6.  CRISPR-based technologies: prokaryotic defense weapons repurposed.

Authors:  Rebecca M Terns; Michael P Terns
Journal:  Trends Genet       Date:  2014-02-18       Impact factor: 11.639

7.  Recognition and cleavage of a nonstructured CRISPR RNA by its processing endoribonuclease Cas6.

Authors:  Yaming Shao; Hong Li
Journal:  Structure       Date:  2013-03-05       Impact factor: 5.006

Review 8.  CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.

Authors:  M Sachdeva; N Sachdeva; M Pal; N Gupta; I A Khan; M Majumdar; A Tiwari
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

Review 9.  Functional advantages conferred by extracellular prokaryotic membrane vesicles.

Authors:  Andrew J Manning; Meta J Kuehn
Journal:  J Mol Microbiol Biotechnol       Date:  2013-04-18

10.  Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III.

Authors:  Lisa Nickel; Katrin Weidenbach; Dominik Jäger; Rolf Backofen; Sita J Lange; Nadja Heidrich; Ruth A Schmitz
Journal:  RNA Biol       Date:  2013-04-25       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.